Research And Development
You can buy or sell ACAD and other stocks, options, ETFs, and crypto commission-free!
ACADIA Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system, or CNS, disorders. It operates through development and commercialization of innovative medicines segment. Read More The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.
San Diego, California
52 Week High
52 Week Low
Research And Development
Yahoo FinanceMay 9
Edited Transcript of ACAD earnings conference call or presentation 1-May-19 8:30pm GMT
Q1 2019 ACADIA Pharmaceuticals Inc Earnings Call SAN DIEGO May 9, 2019 (Thomson StreetEvents) -- Edited Transcript of ACADIA Pharmaceuticals Inc earnings conference call or presentation Wednesday, May 1, 2019 at 8:30:00pm GMT TEXT version of Transcript ================================================================================ Corporate Participants ================================================================================ * Elena H. Ridloff ACADIA Pharmaceuticals Inc. - Executive VP & CFO...
The Motley FoolMay 8
Why Acadia Pharmaceuticals Stock Slumped in April
What happened Acadia Pharmaceuticals (NASDAQ:ACAD), a mid-cap biopharma, saw its shares decline by 10.8% last month, according to data from S&P Global Market Intelligence. What provoked this double-digit sell-off? Acadia's shares fell victim to the politically charged drug-pricing debate in the United States. While biopharma stocks in general struggled in April because of this hot-button issue, Acadia's shares were hit particularly hard because the company has aggressively raised the price of its Parkinso...
Yahoo FinanceMay 7
ACADIA Pharmaceuticals to Present at the Bank of America Merrill Lynch Health Care Conference 2019
SAN DIEGO--(BUSINESS WIRE)-- ACADIA Pharmaceuticals Inc. (ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will present at the Bank of America Merrill Lynch Health Care Conference 2019 on Tuesday, May 14, 2019 at 10:40 a.m. Pacific Time in Las Vegas. A live webcast of ACADIA’s presentation will be accessible on the company’s website, www.acadia-pharm.com,...
Expected Aug 6, After Hours